Neurology® Podcast

Variation in Endpoints for FDA Approved Migraine Therapies

09.07.2023 - By American Academy of NeurologyPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Dr. Jessica Ailani talks with Dr. Aaron Kesselheim and Leigh Sharpless about the endpoints used in trials supporting the US FDA approval of medications treating migraines.  Read the related article in Neurology. This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

More episodes from Neurology® Podcast